Imagine a future without type 1 diabetes (T1D).

Stanford TrialNet offers no cost risk screening for relatives (both adults and children) of people who have T1D, and innovative clinical studies testing ways to slow down and prevent disease progression. TrialNet is an international network of leading academic institutions, endocrinologists, physicians, scientists and healthcare teams at the forefront of T1D research. Our goal: a future without T1D.

If you have a relative with T1D, you are in a unique position to help us learn more about the disease and how to prevent it. TrialNet risk screening uses a simple blood test that can detect your risk of T1D years before symptoms may appear. Early detection is critical. If you are in the early stages of T1D, you may be eligible for a prevention study. Take the first step and get screened.

With three convenient screening options, getting screened is easier than ever. We can help you schedule an in-person appointment at Stanford, order an in-home test kit, or order a test kit to take to a local lab – all at no cost to you.

1.      Have a blood relative with type 1 diabetes diagnosed by the age of 40 and started on insulin therapy within one year of diagnosis (exceptions  may apply; discuss with study coordinator)

2.      Be aged 2.5 to 45 years and have a sibling, child, or parent with T1D

3.      Be aged 2.5 to 20 years and have a niece, nephew, aunt, uncle, grandparent, cousin, or half sibling with T1D

4.      Be a non-relative individual but previously tested positive for diabetes-related autoantibodies outside of TrialNet (discuss with study coordinator)

• 1.            Have been diagnosed with type 1 diabetes by the 2011 ADA criteria

If you are interested in learning more about this study, please reach out to one of the research coordinators listed on the right. You may also download the consent form, assent form, and informational study documents linked on the right.